{"title":"In vivo, In vitro and Molecular Modelling Analysis of Isoquercetin, Roseoside, Coreximine, Anonaine, and Arianacin Molecules.","authors":"Fatma Kubra Ata, F. Ercan, Serap Yalçın Azarkan","doi":"10.2174/1573409918666220509213313","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nAnnona muricata is a member of the Annonaceae family. This plant has a high concentration of Acetogenin, which gives it excellent therapeutic powers. Researchers have tested this miraculous herb in the treatment of breast cancer cells and observed that it can be a source of anticancer.\n\n\nOBJECTIVE\nThe proposed study focused on screening potent the anticancer biological activity of Annona muricata plant by the in-vitro, in-vivo, and in-silico method.\n\n\nMETHODS\nIn-vitro analysis, the IC50 was determined on two-dimensional and three-dimensional breast cancer cells. 2D cells were grown on flat dishes typically made of plastic, while 3D cells were grown using the hanging drop method. İn-vivo analysis, Drosophila melanogaster was preferred and the LC50 was determined. In-silico analysis, molecular docking studies have been carried out on the different classes of Annona muricata Acetogenins against the target proteins. Nearly five Acetogenins were selected from the literature and docking was performed against human Bcl-2, Bad and Akt-1 proteins.\n\n\nRESULTS\nIn-vitro and in-vivo results revealed the IC50 value of 2D MDA-MB-231 cells was 330 μg.mℓ-1, 2D MCF-7 cells were 290 μg.mℓ-1, 3D MCF-7 and MDA-MB-231 cells were about 0.005 g.mℓ-1, and LC50 of Drosophila melanogaster was determined as 0.1 g.mℓ-1. In-silico results revealed the docked complex formed by Isoquercetin showed better binding affinity towards target proteins.\n\n\nCONCLUSION\nAs a result of the analysis, the Annona muricata plant has been observed to be effective against cancer and likely to be a potential drug.","PeriodicalId":10886,"journal":{"name":"Current computer-aided drug design","volume":"1 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current computer-aided drug design","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1573409918666220509213313","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Annona muricata is a member of the Annonaceae family. This plant has a high concentration of Acetogenin, which gives it excellent therapeutic powers. Researchers have tested this miraculous herb in the treatment of breast cancer cells and observed that it can be a source of anticancer.
OBJECTIVE
The proposed study focused on screening potent the anticancer biological activity of Annona muricata plant by the in-vitro, in-vivo, and in-silico method.
METHODS
In-vitro analysis, the IC50 was determined on two-dimensional and three-dimensional breast cancer cells. 2D cells were grown on flat dishes typically made of plastic, while 3D cells were grown using the hanging drop method. İn-vivo analysis, Drosophila melanogaster was preferred and the LC50 was determined. In-silico analysis, molecular docking studies have been carried out on the different classes of Annona muricata Acetogenins against the target proteins. Nearly five Acetogenins were selected from the literature and docking was performed against human Bcl-2, Bad and Akt-1 proteins.
RESULTS
In-vitro and in-vivo results revealed the IC50 value of 2D MDA-MB-231 cells was 330 μg.mℓ-1, 2D MCF-7 cells were 290 μg.mℓ-1, 3D MCF-7 and MDA-MB-231 cells were about 0.005 g.mℓ-1, and LC50 of Drosophila melanogaster was determined as 0.1 g.mℓ-1. In-silico results revealed the docked complex formed by Isoquercetin showed better binding affinity towards target proteins.
CONCLUSION
As a result of the analysis, the Annona muricata plant has been observed to be effective against cancer and likely to be a potential drug.
期刊介绍:
Aims & Scope
Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.
Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews, original research articles and letter articles written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, theoretical chemistry; computational chemistry; computer and molecular graphics; molecular modeling; protein engineering; drug design; expert systems; general structure-property relationships; molecular dynamics; chemical database development and usage etc., providing excellent rationales for drug development.